Measuring the Contribution of Modern Biotechnology to the Canadian Economy

Ricardo de Avillez (ricardo.avillez@csls.ca)

No 2011-18, CSLS Research Reports from Centre for the Study of Living Standards

Abstract: The role of modern biotechnology in agriculture, medicine, and industry has increased dramatically since the 1970s. Despite its growing importance, few efforts have been made so far to estimate the economic contribution of modern biotechnology to the Canadian economy. This report provides an overview of biotechnology activities in Canada, and, using an income-based approach, estimates that biotechnology activities accounted for approximately $15 billion in 2005, equivalent to 1.19 per cent of Canada’s GDP in that year. The report also forecasts that the role of biotechnology in the economy will increase substantially in the next twenty years, representing between 2.6 per cent and 6.0 per cent of Canada’s GDP in 2030.

Date: 2011-12
New Economics Papers: this item is included in nep-agr
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://www.csls.ca/reports/csls2011-18.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sls:resrep:1118

Ordering information: This working paper can be ordered from
http://www.csls.ca
info@csls.ca

Access Statistics for this paper

More papers in CSLS Research Reports from Centre for the Study of Living Standards 170 Laurier Ave. W, Suite 604, Ottawa, ON K1P 5V5. Contact information at EDIRC.
Bibliographic data for series maintained by CSLS (csls@csls.ca this e-mail address is bad, please contact repec@repec.org).